Adc Therapeutics SA (NYSE:ADCT)’s traded shares stood at 0.55 million during the last session, with the company’s beta value hitting 1.56. At the close of
In last trading session, Adc Therapeutics SA (NYSE:ADCT) saw 0.39 million shares changing hands with its beta currently measuring 1.56. Company’s recent per share price
During the last session, Adc Therapeutics SA (NYSE:ADCT)’s traded shares were 0.64 million, with the beta value of the company hitting 1.55. At the end
Adc Therapeutics SA (NYSE:ADCT)’s traded shares stood at 0.74 million during the last session, with the company’s beta value hitting 1.54. At the close of
In last trading session, Adc Therapeutics SA (NYSE:ADCT) saw 1.14 million shares changing hands with its beta currently measuring 1.57. Company’s recent per share price
In recent trading session, Adc Therapeutics SA (NYSE:ADCT) saw 0.41 million shares changing hands at last check today with its beta currently measuring 1.57. Company’s
Adc Therapeutics SA (NYSE:ADCT) has a beta value of 1.55 and has seen 2.07 million shares traded in the last trading session. The company, currently
Adc Therapeutics SA (NYSE:ADCT) has a beta value of 1.54 and has seen 1.47 million shares traded in the last trading session. The company, currently
In the last trading session, 2.27 million shares of the Adc Therapeutics SA (NYSE:ADCT) were traded, and its beta was 1.50. Most recently the company’s
In the last trading session, 3.17 million shares of the Adc Therapeutics SA (NYSE:ADCT) were traded, and its beta was 1.52. Most recently the company’s
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
